Vamorolone is an investigational drug that was developed as a dissociative steroid. This means that its chemical profile is such that it may be shown to chemically separate the aspects of efficacy (clinical benefit) from safety concerns (side effect profiles).

Vamorolone is being tested in children that are otherwise chronically treated with corticosteroids. It is hoped that this is the patient population where it may show the most benefit.